Dimensional Fund Advisors LP Unity Biotechnology, Inc. Transaction History

Dimensional Fund Advisors LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$0.72 - $1.86 $26,043 - $67,278	-36,171 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$1.3 - $3.17 $657 - $1,604	506 Added 1.42%	36,171 $53,000
Q3 2021 Nov 12, 2021	SELL	$2.91 - $4.5 $38,804 - $60,007	-13,335 Reduced 27.21%	35,665 $107,000
Q2 2021 Aug 12, 2021	BUY	$4.15 - $6.3 $1,394 - $2,116	336 Added 0.69%	49,000 $227,000
Q1 2021 May 14, 2021	BUY	$5.51 - $9.42 $268,138 - $458,414	48,664 New	48,664 $292,000

4.41M

Ticker UBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,036,200
Market Cap $14.5M
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.